Clinical Trial Update: Pharmacokinetics Study of ALO-02 and OxyContin [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study comparing ALO-02 and OxyContin (oxycodone) for the management of moderate to severe pain has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• ALO-02 (oxycodone/naloxone)
• OXYCONTIN (OXYCODONE HYDROCHLORIDE)

Snippet

Sponsor: Pfizer | Conditions: Management of Moderate to Severe Pain | Phase 1 | Status: COMPLETED